Is Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 39.3% / 30% | 64.3% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 39.3% / 33% | 64.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 46.8% / 33% | 76.6% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 39.3% / 33% | 64.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 46.8% / 33% | 76.6% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -27176.2% | |
| Return on Assets (ROA) | -323.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$7M |
| Free Cash Flow | -$7M |
| Total Debt | $1M |
| Debt-to-Equity | 47.9 |
| Current Ratio | 1.7 |
| Total Assets | $3M |
Price & Trading
| Last Close | $0.86 |
| 50-Day MA | $1.31 |
| 200-Day MA | $2.66 |
| Avg Volume | 2.7M |
| Beta | 0.6 |
|
52-Week Range
$0.52
| |
About Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Shuttle Pharmaceuticals Holdings, Inc. (SHPH) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Shuttle Pharmaceuticals Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Shuttle Pharmaceuticals Holdings, Inc.'s debt ratio?
Shuttle Pharmaceuticals Holdings, Inc.'s debt ratio is 39.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 46.8%.
What are Shuttle Pharmaceuticals Holdings, Inc.'s key financial metrics?
Shuttle Pharmaceuticals Holdings, Inc. has a market capitalization of $4M. Return on equity stands at -27176.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.